4-[6-(4-Methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2-nitrobenzenamine, 98%, 250mg

5-(4-Methyl-1,3-dioxolan-2-yl)benzo[d][1,3]dioxole, 99.0%, 100g

N-Chloromethylphthalimide [for HPLC Labeling]>98.0%(HPLC)(T)5g

3-(3-Methoxyphenyl)acrylic acid, 95.0%, 10g

4-ETHYNYLTETRAHYDRO-2H-THIOPYRAN, 95.0%, 1g

H-Tyr(Bzl)-OMe.HCl, 95%, 10g

5-Bromo-2-chloro-1,3-diiodobenzene, 98%, 5g

2-(1,6-Naphthyridin-2-yl)benzoic acid hydrate, 95.0%, 10g

Solfato di sodio, minimo 98,5%, Ph.Eur., anidro, 5 kg, confezione in plastica.

(R)-tert-Butyl 3-methyl-1-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate, 95%, 100mg

(R)-N-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-2-((S)-1-(N-hydroxyformamido)ethyl)-5-phenylpentanamide, 95%, 1mg

4-(Trifluoromethyl)salicylic acid, 98.0%, 1kg

5-Phenylcyclohexane-1,3-dione, 98.0%, 5g